(r)-3-hydroxybutanoic acid

(r)-3-hydroxybutanoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 2725 references associated with (r)-3-hydroxybutanoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for (r)-3-hydroxybutanoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with (r)-3-hydroxybutanoic acid

MeSH term MeSH ID Detail
Shock D012769 11 associated lipids
Congenital Abnormalities D000013 11 associated lipids
Amyotrophic Lateral Sclerosis D000690 11 associated lipids
Hypocalcemia D006996 12 associated lipids
Disease Resistance D060467 12 associated lipids
Abortion, Spontaneous D000022 12 associated lipids
Death, Sudden D003645 12 associated lipids
Cat Diseases D002371 12 associated lipids
Metabolic Diseases D008659 12 associated lipids
Critical Illness D016638 13 associated lipids
Glucose Intolerance D018149 13 associated lipids
Hypoglycemia D007003 13 associated lipids
Acidosis D000138 13 associated lipids
Ketosis D007662 13 associated lipids
Corneal Diseases D003316 13 associated lipids
Reye Syndrome D012202 14 associated lipids
Brain Neoplasms D001932 15 associated lipids
Alcoholic Intoxication D000435 15 associated lipids
Respiratory Distress Syndrome, Adult D012128 15 associated lipids
Diabetic Ketoacidosis D016883 16 associated lipids
Liver Cirrhosis, Alcoholic D008104 17 associated lipids
Parkinson Disease, Secondary D010302 17 associated lipids
Escherichia coli Infections D004927 17 associated lipids
Albuminuria D000419 18 associated lipids
Pregnancy Complications D011248 19 associated lipids
Heart Defects, Congenital D006330 20 associated lipids
Vomiting D014839 21 associated lipids
Hyperglycemia D006943 21 associated lipids
Cachexia D002100 21 associated lipids
Carcinoma 256, Walker D002279 22 associated lipids
Malaria, Falciparum D016778 22 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Birth Weight D001724 23 associated lipids
Cholestasis D002779 23 associated lipids
Hypoxia D000860 23 associated lipids
Cattle Diseases D002418 24 associated lipids
Mitochondrial Diseases D028361 25 associated lipids
Lipid Metabolism, Inborn Errors D008052 26 associated lipids
Mammary Neoplasms, Animal D015674 27 associated lipids
Hyperinsulinism D006946 27 associated lipids
Obesity D009765 29 associated lipids
Liver Diseases D008107 31 associated lipids
Hypothyroidism D007037 32 associated lipids
Neurodegenerative Diseases D019636 32 associated lipids
Uremia D014511 33 associated lipids
Neurotoxicity Syndromes D020258 34 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Epilepsy D004827 35 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Per page 10 20 50 100 | Total 185

PubChem Associated disorders and diseases

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with (r)-3-hydroxybutanoic acid

Download all related citations
Per page 10 20 50 100 | Total 2707
Authors Title Published Journal PubMed Link
Styrud J and Eriksson UJ Effects of D-glucose and beta-hydroxybutyric acid on the in vitro development of (pre)chondrocytes from embryos of normal and diabetic rats. 1990 Acta Endocrinol. pmid:2333734
Gillmer MD et al. Low energy diets in the treatment of gestational diabetes. 1986 Acta Endocrinol Suppl (Copenh) pmid:3532669
Aarsen RS et al. Long-acting somatostatin analogue (Sandostatin) reduces late night insulinopenic ketogenesis in diabetic teenagers. 1987 Acta Endocrinol Suppl (Copenh) pmid:2892337
Avogaro A et al. Ketone body kinetics in vivo using simultaneous administration of acetoacetate and 3-hydroxybutyrate labelled with stable isotopes. 1990 Jan-Mar Acta Diabetol Lat pmid:2336923
Al-Awadi F and Shoukry M The lipid lowering effect of an anti-diabetic plant extract. 1988 Jan-Mar Acta Diabetol Lat pmid:3407374
Stangenberg M et al. Effect of treatment with insulin or diet on intermediary metabolites in pregnant women with chemical diabetes in the third trimester of pregnancy. 1984 Jan-Mar Acta Diabetol Lat pmid:6375226
Micossi P et al. Metabolic instability in type I diabetic patients. Studies on insulin absorption, hepatic production of metabolites and glucose counterregulation. 1985 Jul-Sep Acta Diabetol Lat pmid:3907236
Gregorio F et al. Low dose metformin in the treatment of type II non-insulin-dependent diabetes: clinical and metabolic evaluations. 1990 Apr-Jun Acta Diabetol Lat pmid:2198745
Hoque MM et al. Structure of D-3-hydroxybutyrate dehydrogenase prepared in the presence of the substrate D-3-hydroxybutyrate and NAD+. 2009 Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. pmid:19342772
Faria MH et al. Ketone bodies metabolism during ischemic and reperfusion brain injuries following bilateral occlusion of common carotid arteries in rats. 2007 Mar-Apr Acta Cir Bras pmid:17375219